Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants.Minerva and the FDA ...

CT-155 is a smartphone app that integrates psychosocial interventions delivered using an adaptive goal-setting technique. A ...

Minerva Neurosciences Inc (NASDAQ:NERV) shares are climbing Tuesday after the company announced up to $200 million in funding ...

Shares surged 141% to $6.41, marking their highest level since February 2024, after Minerva secured up to $200 million in ...

German drugmaker Boehringer Ingelheim and Click Therapeutics said their phase 3 trial of a prescription digital therapeutic ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. First, let me ...

Boehringer Ingelheim and Click Therapeutics have revealed the data from their pivotal trial of digital therapeutic (DTx) ...

Minerva Neurosciences (NASDAQ:NERV) shares rose as much as 160% premarket on Tuesday after announcing financing of as much as ...

Panelists discuss how negative symptoms create significant patient burden by appearing during the prodromal period in late adolescence and requiring a comprehensive biopsychosocial treatment approach ...

Boehringer Ingelheim and Click Therapeutics today shared data from the pivotal Phase III CONVOKE study (NCT05838625) of CT-155 (BI 3972080), an investigational prescription digital therapeutic ...

Folate, found in meat and leafy greens, is an important vitamin for neuron function. In some cases, it may be even more important for those whose brains are struggling with energy regulation, such as ...